image
Healthcare - Biotechnology - NASDAQ - US
$ 2.85
-2.06 %
$ 25.4 M
Market Cap
-0.5
P/E
BALANCE SHEET
27.3 M ASSETS
-47.77%
36.2 M LIABILITIES
-7.08%
-8.86 M EQUITY
-66.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Clene Inc.
image
Current Assets 16.2 M
Cash & Short-Term Investments 12.2 M
Receivables 391 K
Other Current Assets 3.61 M
Non-Current Assets 11.2 M
Long-Term Investments 0
PP&E 11.1 M
Other Non-Current Assets 58 K
44.46 %13.21 %40.68 %Total Assets$27.3m
Current Liabilities 10.3 M
Accounts Payable 1.24 M
Short-Term Debt 359 K
Other Current Liabilities 8.69 M
Non-Current Liabilities 25.9 M
Long-Term Debt 19.6 M
Other Non-Current Liabilities 6.35 M
3.43 %24.02 %54.04 %17.53 %Total Liabilities$36.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 12.2 28.8 18.3 50.3 59.3 8.8 0.7
Short Term Investments 0 6.2 5.0 0 0 0 0
Receivables 0.4 1.3 0.2 1.6 2.2 0 0
Inventory 68 K 37 K 43 K 41 K 0.2 28 K 0
Other Current Assets 3.5 2.5 5.6 2.6 1.4 0.7 46.7 K
Total Current Assets 16.2 38.9 29.2 54.6 63.0 9.5 0.8
PP&E 11.1 13.4 15.2 8.4 5.3 5.4 4.5
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 58 K 58 K 0 0 46.4
Other Long Term Assets 58 K 58 K 0 0 (0.3) (5.4) (4.5)
Other Assets 0 0 0 0 0 0 0
Total Assets 27.3 52.3 44.5 63.1 68.2 14.9 47.2
LIABILITIES
Accounts Payable 1.2 1.5 3.0 1.9 1.1 0.9 1.1
Short Term Debt 0.4 20.1 7.5 1.0 0.8 0.3 3.1
Other Current Liabilities 8.7 3.7 3.3 3.1 9.5 2.9 1.1
Total Current Liabilities 10.3 25.3 13.9 6.0 11.7 4.3 0.2
Long Term Debt 19.6 12.1 24.8 23.5 3.9 2.5 0.2
Deferred Tax Income 0 0 0 0 0.3 (1.8) (0.2)
Other Liabilities 6.3 1.6 2.6 20.9 52.0 75.9 39.9
Total Liabilities 36.2 39.0 41.3 50.5 67.9 82.7 42.2
EQUITY
Common Stock 1 K 13 K 7 K 6 K 6 K 2 K 199
Retained Earnings (282.1) (242.7) (193.2) (163.3) (153.6) (69.6) 17 K
Other Accumulative Comprehensive Income/Loss 71 K 0.2 0.2 0.2 0.3 41 K 27.2 K
Total Equity (8.9) 13.4 3.2 12.6 0.3 (67.8) 5.0
Total Liabilities and Equity 27.3 52.3 44.5 63.1 68.2 14.9 47.2
SHARES OUTSTANDING
Common Shares Outstanding 7.0 5.2 3.3 3.1 3.5 3.5 3.1 3.1